Neuraline
Back to ResourcesScreening & Assessment

GAD-7 Score Interpretation & Calculator: Free 0–21 Scoring

Updated 2026-11-1610 min read

The GAD-7 (Generalized Anxiety Disorder 7-item scale) is the standard brief screener for generalized anxiety disorder — and, like the PHQ-9 for depression, it doubles as a severity tracker during treatment. Seven items, a 0–21 total score, and validated severity bands make it the go-to anxiety measure in primary care and behavioral health.

Quick answer: The GAD-7 is a validated 7-item anxiety screener scored 0–21. Severity bands: 0–4 minimal, 5–9 mild, 10–14 moderate, 15–21 severe. A score ≥10 is the positive-screen cutoff for generalized anxiety disorder. It is routinely paired with the PHQ-9 depression screener in measurement-based care.

Interactive Screening Calculator

PHQ-9 · GAD-7 · PHQ-2 — live scoring, no signup

PHQ-9 — Depression (9 items, 0–27)

1. Little interest or pleasure in doing things

2. Feeling down, depressed, or hopeless

3. Trouble falling or staying asleep, or sleeping too much

4. Feeling tired or having little energy

5. Poor appetite or overeating

6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down

7. Trouble concentrating on things

8. Moving or speaking so slowly others noticed, or being so fidgety/restless you have been moving around a lot more than usual

9. Thoughts that you would be better off dead, or of hurting yourself in some way

0/9 answered

GAD-7 — Anxiety (7 items, 0–21)

1. Little interest or pleasure in doing things

2. Feeling down, depressed, or hopeless

3. Trouble falling or staying asleep, or sleeping too much

4. Feeling tired or having little energy

5. Poor appetite or overeating

6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down

7. Trouble concentrating on things

0/7 answered

PHQ-9 Total

0/27
Minimal depressionScreen negative

Suggested ICD-10-CM if criteria met: F32.9/F33.9 · CPT 96127 billable when staff-administered & scored

GAD-7 Total

0/21
Minimal anxietyScreen negative

Suggested ICD-10-CM if criteria met: F41.1 · CPT 96127 billable when staff-administered & scored

Educational tool — not a diagnosis. Results require interpretation by a qualified clinician. This screen does not replace the DSM-5-TR clinical interview.

This guide covers scoring, interpretation, and the clinical workflow around the GAD-7.

Background: How the GAD-7 Was Developed and Validated

The GAD-7 was developed by Spitzer, Kroenke, Williams, and Löwe and validated in a 2006 study published in Archives of Internal Medicine across roughly 2,740 primary care patients. It was derived from the anxiety module of the PRIME-MD diagnostic interview — distilled into a 7-item self-report that takes about 2 minutes to complete.

At the ≥10 cutoff, the GAD-7 achieves roughly 89% sensitivity and 82% specificity for generalized anxiety disorder, and it performs well as a broad screen for any anxiety disorder — elevated scores also appear in panic disorder, social anxiety disorder, and PTSD. The instrument is free to use in clinical practice and is available in multiple validated translations.

The GAD-7 was designed as the anxiety counterpart to the PHQ-9 depression screener — same research group, same 0–3 response scale, same "past 2 weeks" frame. Administering both takes under 5 minutes and covers the two most common behavioral health presentations.

The 7 Items

Each item asks about symptoms over the past 2 weeks. Response options are identical for all items:

ResponsePoints
Not at all0
Several days1
More than half the days2
Nearly every day3
#Item (abbreviated)
1Feeling nervous, anxious, or on edge
2Not being able to stop or control worrying
3Worrying too much about different things
4Trouble relaxing
5Being so restless that it is hard to sit still
6Becoming easily annoyed or irritable
7Feeling afraid as if something awful might happen

Scoring

Sum all seven item scores. Total range: 0–21.

StepCalculation
Item scoresEach item: 0, 1, 2, or 3
Total scoreSum of items 1–7
Possible range0 (no anxiety symptoms) to 21 (all symptoms nearly every day)

Severity Bands

The GAD-7 total maps to four severity categories:

Total scoreSeverityClinical meaning
0–4Minimal anxietyFew or no symptoms; routine care
5–9Mild anxietySubthreshold or mild symptoms; watchful waiting, lifestyle measures, rescreen
10–14Moderate anxietyPositive screen for generalized anxiety disorder; treatment recommended
15–21Severe anxietyActive treatment indicated — therapy, medication, or both

The ≥10 Cutoff — What It Means

A GAD-7 score of 10 or higher is the validated positive-screen threshold for generalized anxiety disorder:

PropertyValue
Cutoff≥10
Sensitivity~89%
Specificity~82%
ReferenceSpitzer, Kroenke, Williams & Löwe, Arch Intern Med 2006

A score ≥10 does not diagnose GAD — it identifies patients who need a clinical interview to establish DSM-5-TR criteria (excessive worry, difficulty controlling worry, associated symptoms, ≥6 months duration, functional impairment). Document both the screen result and the interview findings separately.

GAD-7 Beyond GAD — What Else It Detects

The GAD-7 was designed for generalized anxiety but performs well as a broad anxiety screener:

ConditionGAD-7 performance
Generalized anxiety disorderPrimary target — best validated
Panic disorderElevated scores common; does not distinguish panic from GAD
Social anxiety disorderElevated scores; screen with dedicated measures for specificity
PTSDElevated scores reflect hyperarousal/avoidance overlap; use PCL-5 for PTSD screening
Any anxiety disorderGAD-7 ≥10 has good sensitivity for "any anxiety disorder" as a category

GAD-7 + PHQ-9 — The Standard Pair

GAD-7 and PHQ-9 are almost always administered together because anxiety and depression co-occur at high rates (~60% comorbidity in clinical samples):

Combined patternInterpretation
PHQ-9 ≥10, GAD-7 <10Depression positive, anxiety negative
PHQ-9 <10, GAD-7 ≥10Anxiety positive, depression negative
Both ≥10Comorbid depression + anxiety — common; assess both, consider combined treatment
Both <10Neither screen positive — routine care

Administering both takes under 5 minutes total and gives a complete picture of the two most common behavioral health presentations.

Functional Impairment Question (Q8)

The GAD-7 includes an optional 8th question (not scored): "If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?" — rated 0 (not difficult) to 3 (extremely difficult).

Q8 scoreUse
0–1Symptoms may not meet functional-impairment criterion
2–3Supports clinically significant impairment — relevant for DSM-5-TR criterion F

Clinical Workflow

StepAction
1. AdministerPatient completes GAD-7 (paper, portal, or tablet) — takes ~2 minutes
2. ScoreSum items; apply severity bands
3. Interpret≥10 → positive screen; 5–9 → monitor/rescreen; <5 → routine
4. Pair with PHQ-9Depression-anxiety comorbidity check
5. DiagnosePositive screen → clinical interview for DSM-5-TR criteria
6. TrackRepeat GAD-7 every 2–4 weeks during active treatment to measure response

Scoring Examples

ScenarioItems patternTotalSeverity
No symptomsAll 0s0Minimal
Occasional worrySeveral 1s5–9Mild
Moderate anxietyMix of 1s, 2s, a few 3s10–14Moderate
Severe anxietyMostly 2s and 3s15–21Severe

GAD-7 vs. GAD-2 — The Ultra-Brief Pre-Screen

The first two items alone form the GAD-2, a 2-item ultra-brief screen:

GAD-2 scoreInterpretation
0–2Negative — anxiety unlikely; no further screening needed
≥3Positive — administer full GAD-7

The GAD-2 exists for time-constrained settings (annual wellness visits, busy intake) — it trades some accuracy for speed, the same way the PHQ-2 does for depression.

Special Populations

PopulationRecommendation
Perinatal patientsThe EPDS (Edinburgh Postnatal Depression Scale) includes anxiety items and is preferred in pregnancy/postpartum; GAD-7 is acceptable and widely used
Older adultsGAD-7 performs well, but somatic items (restlessness, trouble relaxing) can be inflated by medical illness or medication effects — interpret with clinical context
AdolescentsGAD-7 is validated down to roughly age 12; pair with clinical interview given developmental expression of anxiety
Chronic medical illnessSomatic overlap (fatigue, restlessness) can inflate scores — track item trends rather than totals alone
Cultural/linguistic diversityUse validated translations; pair scores with clinical interview since distress expression varies culturally

Payer Requirements for Anxiety Screening

ProgramRequirementGAD-7 role
Medicare Annual Wellness VisitDepression screening is required (G0444); anxiety screening supports the visit's behavioral health reviewGAD-7 documents the anxiety assessment
HEDIS / payer quality programsDocumented screening for behavioral health populationsScored GAD-7 with severity interpretation
CPT 96127Staff-administered test administration + scoring, billableSee billing section below

Automated Scoring in Neuraline

Neuraline's AI Screening module ships with GAD-7 pre-seeded — alongside PHQ-9, Y-BOCS, BDI, HAM-D, MMSE, AUDIT, and CAGE — so scores compute automatically the moment a patient submits:

CapabilityHow it works
Auto-scoringTotal score, severity band, and trend computed instantly — no hand tallying
PHQ-9 pairingAdminister GAD-7 + PHQ-9 together; both scores land on the chart
Portal administrationAssign GAD-7 to patients; they complete it before the visit
Encounter administrationAdminister and score during the visit
AI interpretationPlain-language interpretation, clinical implications, and risk level
3-click AI ChartingThe score flows into the encounter note — draft, review, sign in three clicks

The chart documents the instrument, score, severity, and interpretation automatically — audit-ready for CPT 96127 claims and payer quality reporting.

Billing: CPT 96127

When staff administer and score the GAD-7, the work is billable under CPT 96127 — psychological or neuropsychological test administration with scoring by a practice staff member under physician or qualified healthcare professional supervision, per hour of staff time:

RuleDetail
Who billsThe supervising physician or qualified healthcare professional
Time rulePer hour of staff time; 16-minute minimum (one unit typically covers a screening session)
FrequencyMost payers allow one unit per patient per day
Same-day E/MGenerally billable alongside an E/M visit — document the screening separately
DocumentationInstrument name, administration date, raw score, severity interpretation, staff time, supervising provider
Typical reimbursementRoughly $1–2 per unit (varies by payer and region)

Tip: when GAD-7 and PHQ-9 are administered in the same session, document both under the same 96127 unit — the 16-minute minimum covers the combined administration.

Download the Free GAD-7 PDF

Need a printable worksheet? Get the free GAD-7 anxiety screening form — plus PHQ-9, PCL-5, ASRS, C-SSRS, EPDS, and MDQ — in the Screening PDFs Library. All worksheets are free; scoring guides for each instrument are linked there too.

Frequently Asked Questions

Is the GAD-7 a diagnostic test for GAD only?

No — it screens for generalized anxiety disorder but elevated scores also appear in panic disorder, social anxiety disorder, and PTSD. It is best used as a broad anxiety screener plus severity tracker, not a standalone diagnostic tool.

How often should GAD-7 be repeated?

During active treatment, every 2–4 weeks is standard for monitoring response. A drop of ≥4 points is considered a clinically meaningful improvement.

Can GAD-7 be used for billing?

Yes — anxiety screening measures support medical necessity for behavioral health services and are commonly required by payers for anxiety treatment authorization. Document the score, date, and clinical interpretation.

What if GAD-7 is high but PHQ-9 is low?

This pattern suggests anxiety without depression — still warrants clinical evaluation. Anxiety disorders are the most common mental health condition in the US (~19% annual prevalence) and frequently present without comorbid depression.


This guide summarizes GAD-7 scoring for clinical reference. Always verify scoring against the official instrument and your organization's protocols.

Score GAD-7 and PHQ-9 automatically in Neuraline — seeded screening instruments with severity bands and alert thresholds. Explore screening or book a demo.

gad-7anxiety screeningscoringgeneralized anxiety disordermeasurement-based carebehavioral healthgad-7 scoring interpretationgad-7 score interpretationgad 7 scoringcpt 96127gad 7 scoresgad scoringgad-7 questionnairegad-7 pdfphq-9 and gad-7 scoring